Global impact of rotavirus vaccines

References

• Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg. Infect. Dis.12(2), 304–306 (2006).
   PubMed Web of Science ®Google Scholar
• Parashar UD, Burton A, Lanata C et al. Global mortality associated with rotavirus disease among children in 2004. J. Infect. Dis.200(Suppl. 1), S9–S15 (2009).
   PubMed Web of Science ®Google Scholar
• Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Rotavirus vaccines: targeting the developing world. J. Infect. Dis.192(Suppl. 1), S160–S166 (2005).
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N. Engl. J. Med.354(1), 11–22 (2006).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N. Engl. J. Med.354(1), 23–33 (2006).
   PubMed Web of Science ®Google Scholar
• Conclusions and recommendations from the Immunization Strategic Advisory Group. Wkly Epidemiol. Rec.81(1), 2–11 (2006).
   Google Scholar
• Meeting of the immunization Strategic Advisory Group of Experts, April 2009 – conclusions and recommendations. Wkly Epidemiol. Rec.84(23), 220–236 (2009).
   PubMedGoogle Scholar
• Rotavirus vaccines: an update. Wkly Epidemiol. Rec.84(51–52), 533–540 (2009).
   PubMedGoogle Scholar
• Meeting of the Strategic Advisory Group of Experts on immunization, October 2009 – conclusions and recommendations. Wkly Epidemiol. Rec.84(50), 517–532 (2009).
   PubMedGoogle Scholar
• Estes MK, Cohen J. Rotavirus gene structure and function. Microbiol. Rev.53(4), 410–449 (1989).
   PubMedGoogle Scholar
• Estes MK, Kapikian AZ. Rotaviruses. In: Field’s Virology (5th Edition). Knipe DM, Howley PM (Eds). Lippincott, Williams and Williams, PA, USA, 1917–1958 (2007).
   Google Scholar
• Gentsch JR, Parashar UD, Glass RI. Impact of rotavirus vaccination: the importance of monitoring strains. Future Microbiol.4, 1231–1234 (2009).
   PubMed Web of Science ®Google Scholar
• Ball JM, Tian P, Zeng CQ, Morris AP, Estes MK. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science272(5258), 101–104 (1996).
   PubMed Web of Science ®Google Scholar
• Rodriguez WJ, Kim HW, Brandt CD et al. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: clinical and epidemiologic observations. Pediatr. Infect. Dis. J.6(2), 170–176 (1987).
   PubMed Web of Science ®Google Scholar
• Glass RI, Kilgore PE, Holman RC et al. The epidemiology of rotavirus diarrhea in the United States: surveillance and estimates of disease burden. J. Infect. Dis.174(Suppl. 1), S5–S11 (1996).
   PubMed Web of Science ®Google Scholar
• Gurwith M, Wenman W, Hinde D, Feltham S, Greenberg H. A prospective study of rotavirus infection in infants and young children. J. Infect. Dis.144(3), 218–224 (1981).
   PubMed Web of Science ®Google Scholar
• Carlson JA, Middleton PJ, Szymanski MT, Huber J, Petric M. Fatal rotavirus gastroenteritis: an analysis of 21 cases. Am. J. Dis. Child.132(5), 477–479 (1978).
   PubMedGoogle Scholar
• Blutt SE, Matson DO, Crawford SE et al. Rotavirus antigenemia in children is associated with viremia. PLoS Med.4(4), e121 (2007).
   PubMed Web of Science ®Google Scholar
• Blutt SE, Kirkwood CD, Parreno V et al. Rotavirus antigenaemia and viraemia: a common event? Lancet362(9394), 1445–1449 (2003).
   PubMed Web of Science ®Google Scholar
• Chiappini E, Azzari C, Moriondo M, Galli L, de Martino M. Viraemia is a common finding in immunocompetent children with rotavirus infection. J. Med. Virol.76(2), 265–267 (2005).
   PubMedGoogle Scholar
• Chitambar SD, Tatte VS, Dhongde R, Kalrao V. High frequency of rotavirus viremia in children with acute gastroenteritis: discordance of strains detected in stool and sera. J. Med. Virol.80(12), 2169–2176 (2008).
   PubMed Web of Science ®Google Scholar
• Ray P, Fenaux M, Sharma S et al. Quantitative evaluation of rotaviral antigenemia in children with acute rotaviral diarrhea. J. Infect. Dis.194(5), 588–593 (2006).
   PubMedGoogle Scholar
• Velazquez FR, Matson DO, Calva JJ et al. Rotavirus infections in infants as protection against subsequent infections. N. Engl. J. Med.335(14), 1022–1028 (1996).
   PubMed Web of Science ®Google Scholar
• Black RE, Lopez de Romana G et al. Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru. Am. J. Epidemiol.129(4), 785–799 (1989).
   PubMed Web of Science ®Google Scholar
• Mrukowicz J, Szajewska H, Vesikari T. Options for the prevention of rotavirus disease other than vaccination. J. Pediatr. Gastroenterol. Nutr.46(Suppl. 2), S32–S37 (2008).
   PubMed Web of Science ®Google Scholar
• Simhon A, Mata L, Vives M et al. Low endemicity and low pathogenicity of rotaviruses among rural children in Costa Rica. J. Infect. Dis.152(6), 1134–1142 (1985).
   PubMed Web of Science ®Google Scholar
• Zaki AM, DuPont HL, el Alamy MA et al. The detection of enteropathogens in acute diarrhea in a family cohort population in rural Egypt. Am. J. Trop. Med. Hyg.35(5), 1013–1022 (1986).
   PubMed Web of Science ®Google Scholar
• Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med.309(2), 72–76 (1983).
   PubMed Web of Science ®Google Scholar
• Snodgrass DR, Wells PW. Rotavirus infection in lambs: studies on passive protection. Arch. Virol.52(3), 201–205 (1976).
   PubMedGoogle Scholar
• Midthun K, Kapikian AZ. Rotavirus vaccines: an overview. Clin. Microbiol. Rev.9(3), 423–434 (1996).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Isolauri E, D’Hondt E, Delem A, Andre FE, Zissis G. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet1(8384), 977–981 (1984).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Isolauri E, Delem A et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J. Pediatr.107(2), 189–194 (1985).
   PubMed Web of Science ®Google Scholar
• Ruuska T, Vesikari T, Delem A, Andre FE, Beards GM, Flewett TH. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J. Infect. Dis.22(3), 269–278 (1990).
   PubMed Web of Science ®Google Scholar
• Vesikari T. Clinical trials of live oral rotavirus vaccines: the Finnish experience. Vaccine11(2), 255–261 (1993).
   PubMedGoogle Scholar
• Vesikari T, Ruuska T, Delem A, Andre FE. Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report. Pediatr. Infect. Dis. J.6(2), 164–169 (1987).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Ruuska T, Delem A, Andre FE, Beards GM, Flewett TH. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr. Scand.80(2), 173–180 (1991).
   PubMed Web of Science ®Google Scholar
• Hanlon P, Hanlon L, Marsh V et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet1(8546), 1342–1345 (1987).
   PubMed Web of Science ®Google Scholar
• De Mol P, Zissis G, Butzler JP, Mutwewingabo A, Andre FE. Failure of live, attenuated oral rotavirus vaccine. Lancet2(8498), 108 (1986).
   PubMed Web of Science ®Google Scholar
• Lanata CF, Black RE, del Aguila R et al. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. J. Infect. Dis.159(3), 452–459 (1989).
   PubMed Web of Science ®Google Scholar
• Georges-Courbot MC, Monges J, Siopathis MR et al. Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa. Res. Virol.142(5), 405–411 (1991).
   PubMedGoogle Scholar
• Flores J, Perez-Schael I, Gonzalez M et al. Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet1(8538), 882–884 (1987).
   PubMed Web of Science ®Google Scholar
• Perez-Schael I, Garcia D, Gonzalez M et al. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J. Med. Virol.30(3), 219–229 (1990).
   PubMed Web of Science ®Google Scholar
• Pérez-Schael I, Guntiñas MJ, Pérez M et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N. Engl. J. Med.337, 1181–1187 (1997).
   PubMed Web of Science ®Google Scholar
• Joensuu J, Koskenniemi E, Pang XL, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet350(9086), 1205–1209 (1997).
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Glass RI, Rodgers G, Davidson BL, Sack DA. Evaluation of rhesus rotavirus monovalent and tetravalent reassortant vaccines in US children. US Rotavirus Vaccine Efficacy Group. JAMA273(15), 1191–1196 (1995).
   PubMed Web of Science ®Google Scholar
• Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.48(RR-2), 1–20 (1999).
   Google Scholar
• Withdrawal of rotavirus vaccine recommendation. MMWR Morb. Mortal. Wkly Rep.48(43), 1007 (1999).
   PubMedGoogle Scholar
• Intussusception among recipients of rotavirus vaccine – United States, 1998–1999. MMWR Morb. Mortal. Wkly Rep.48(27), 577–581 (1999).
   PubMedGoogle Scholar
• Murphy TV, Gargiullo PM, Massoudi MS et al. Intussusception among infants given an oral rotavirus vaccine. N. Engl. J. Med.344(8), 564–572 (2001).
   PubMed Web of Science ®Google Scholar
• Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics110(6), e67 (2002).
   PubMed Web of Science ®Google Scholar
• Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception: the role of age at the time of vaccination. J. Infect. Dis.192(Suppl. 1), S36–S43 (2005).
   PubMed Web of Science ®Google Scholar
• Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J. Infect. Dis.193(6), 898; author reply 898–899 (2006).
   PubMedGoogle Scholar
• Global Advisory Committee on Vaccine Safety, 1–2 December 2005. Wkly Epidemiol. Rec.81(2), 15–19 (2006).
   PubMedGoogle Scholar
• International Medica Foundation. Milestone in Phase II Clinical Trial for Rotavirus Vaccine Reached. International Medica Foundation, MN, USA (2009).
   Google Scholar
• Heaton PM, Goveia MG, Miller JM, Offit P, Clark HF. Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis. J. Infect. Dis.192(Suppl. 1), S17–S21 (2005).
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Smith VE, Sherwood JR et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89–12. Vaccine16(4), 381–387 (1998).
   PubMed Web of Science ®Google Scholar
• De Vos B, Vesikari T, Linhares AC et al. A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis. Pediatr. Infect. Dis. J.23(10 Suppl.), S179–S182 (2004).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet370(9601), 1757–1763 (2007).
   PubMed Web of Science ®Google Scholar
• Linhares AC, Velazquez FR, Perez-Schael I et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled Phase III study. Lancet371(9619), 1181–1189 (2008).
   PubMed Web of Science ®Google Scholar
• Keating GM. Rotavirus vaccine RIX4414 (Rotarix). Paediatr. Drugs8(6), 389–395; discussion 396–387 (2006).
   PubMedGoogle Scholar
• De Vos B, Han HH, Bouckenooghe A et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr. Infect. Dis. J.28(4), 261–266 (2009).
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele AD et al. Impact of human rotavirus vaccine on severe gastroenteritis in African infants: a multicentre clinical trial. N. Engl. J. Med.362(4), 289–298 (2010).
   PubMed Web of Science ®Google Scholar
• Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.58(RR-2), 1–25 (2009).
   PubMedGoogle Scholar
• Boom JA, Tate JE, Sahni LC et al. Effectiveness of Pentavalent rotavirus vaccine in a large, urban US population. Pediatrics125(2), e199–e207 (2010).
   PubMed Web of Science ®Google Scholar
• Tate JE, Panozzo CA, Payne DC et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics124(2), 465–471 (2009).
   PubMed Web of Science ®Google Scholar
• Reduction in rotavirus after vaccine introduction – United States, 2000–2009. MMWR Morb. Mortal. Wkly Rep.58(41), 1146–1149 (2009).
   PubMedGoogle Scholar
• Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in children and correlation with early rotavirus vaccine uptake from a national medical claims database. Pediatr. Infect. Dis. J. (2010) (In Press).
   Google Scholar
• Lambert SB, Faux CE, Hall L et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med. J. Aust.191(3), 157–160 (2009).
   PubMed Web of Science ®Google Scholar
• Snelling TL, Schultz R, Graham J et al. Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting. Clin. Infect. Dis.49(3), 428–431 (2009).
   PubMed Web of Science ®Google Scholar
• Snelling TL, Andrews RM, Kirkwood CD, Carapetis JR. Evaluation of the monovalent human rotavirus vaccine RIX4414 following a G2P[4] outbreak. Presented at: 26th meeting of the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Francisco, CA, USA, 12–15 September 2009.
   Google Scholar
• Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H. Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr. Infect. Dis. J. DOI: 10.1097/INF.0b013e3181c18434 (2009).
   Google Scholar
• Gurgel RQ, Cuevas LE, Vieira SC et al. Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg. Infect. Dis.13(10), 1571–1573 (2007).
   PubMed Web of Science ®Google Scholar
• Gurgel RQ, Correia JB, Cuevas LE. Effect of rotavirus vaccination on circulating virus strains. Lancet371(9609), 301–302 (2008).
   PubMed Web of Science ®Google Scholar
• Nakagomi T, Cuevas LE, Gurgel RG et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch. Virol.153(3), 591–593 (2008).
   PubMed Web of Science ®Google Scholar
• Gurgel RQ, Bohland AN, Vieira SA et al. Incidence of rotavirus and all-cause diarrhea in northeast brazil following the introduction of a national vaccination program. Gastroenterology137, 1970–1975 (2009).
   PubMed Web of Science ®Google Scholar
• Patel MM, de Oliveira LH, Bispo AM, Gentsch J, Parashar UD. Rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg. Infect. Dis.14(5), 863–865 (2008).
   PubMed Web of Science ®Google Scholar
• Correia JB, Patel MM, Nakagomi O et al. Effectiveness of monovalent rotavirus vaccine (rotarix) against severe diarrhoea caused by serotypically-unrelated G2P[4] strains in Brazil. J. Infect. Dis.201(3), 363–369 (2010).
   PubMed Web of Science ®Google Scholar
• Richardson V, Hernandez-Pichardo J, Quintanar-Solares M et al. Reduction in childhood diarrhea deaths after rotavirus vaccine introduction in Mexico. N. Engl. J. Med.362(4), 299–305 (2010).
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, De Oliveira LH et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA301(21), 2243–2251 (2009).
   PubMed Web of Science ®Google Scholar
• Orozco M, Vasquez J, Pedreira C et al. Uptake of rotavirus vaccine and national trends of acute gastroenteritis among children in Nicaragua. J. Infect. Dis.200(Suppl. 1), S125–S130 (2009).
   PubMedGoogle Scholar
• Belongia EA, Irving SA, Shui IM et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr. Infect. Dis. J.29(1), 1–5 (2010).
   PubMed Web of Science ®Google Scholar
• Haber P, Patel M, Izurieta HS et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics121(6), 1206–1212 (2008).
   PubMed Web of Science ®Google Scholar
• Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev. Vaccines8(11), 1555–1564 (2009).
   PubMed Web of Science ®Google Scholar
• Patel NC, Hertel PM, Estes MK et al. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N. Engl. J. Med.362(4), 314–319 (2010).
   PubMed Web of Science ®Google Scholar
• RotaTeq® (Package Insert). Merck & Co., Inc., NJ, USA (2009)
   Google Scholar
• Zaman K, Sack DA, Yunus M et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine27(9), 1333–1339 (2009).
   PubMed Web of Science ®Google Scholar
• Ciarlet M, Sani-Grosso R, Yuan G et al. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine. Pediatr. Infect. Dis. J.27(10), 874–880 (2008).
   PubMed Web of Science ®Google Scholar
• Patel MM, Clark AD, Glass RI et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine27(22), 2916–2922 (2009).
   PubMed Web of Science ®Google Scholar
• Clark A, Sanderson C. Timing of children’s vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet373(9674), 1543–1549 (2009).
   PubMed Web of Science ®Google Scholar
• John TJ. Antibody response of infants in tropics to five doses of oral polio vaccine. Br. Med. J.1(6013), 812 (1976).
   PubMedGoogle Scholar
• John TJ, Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am. J. Epidemiol.96(4), 263–269 (1972).
   PubMed Web of Science ®Google Scholar
• Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev. Infect. Dis.13(5), 926–939 (1991).
   PubMedGoogle Scholar
• Suharyono Simanjuntak C, Witham N et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5–9-year-old Indonesian children. Lancet340(8821), 689–694 (1992).
   PubMed Web of Science ®Google Scholar
• Gotuzzo E, Butron B, Seas C et al. Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels. Infect. Immun.61(9), 3994–3997 (1993).
   PubMed Web of Science ®Google Scholar
• Linhares AC, Gabbay YB, Mascarenhas JD et al. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belem, Brazil. Bull. World Health Organ.74(5), 491–500 (1996).
   PubMed Web of Science ®Google Scholar
• Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J. Infect. Dis.200(Suppl. 1), S39–S48 (2009).
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD, Bresee JS et al. Rotavirus vaccines: current prospects and future challenges. Lancet368(9532), 323–332 (2006).
   PubMed Web of Science ®Google Scholar
• Rennels MB. Influence of breast-feeding and oral poliovirus vaccine on the immunogenicity and efficacy of rotavirus vaccines. J. Infect. Dis.174(Suppl. 1), S107–S111 (1996).
   PubMed Web of Science ®Google Scholar
• Moon KB. Differential rotavirus antibody profiles in breast milk specimens from mothers with infants in developed and developing countries. Presented at: American Society for Virology Conference. Vancouver, BC, Canada, 11–15 July 2009.
   Google Scholar
• Steele AD, De Vos B, Tumbo J et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine DOI:10.1016/j.vaccine.2008.08.034 (2008) (Epub ahead of print).
   PubMedGoogle Scholar
• Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev. Med. Virol.15(1), 29–56 (2005).
   PubMed Web of Science ®Google Scholar
• Sanchez-Padilla E, Grais RF, Guerin PJ, Steele AD, Burny ME, Luquero FJ. Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. Lancet Infect. Dis.9(9), 567–576 (2009).
   PubMed Web of Science ®Google Scholar
• Steele AD, Ivanoff B. Rotavirus strains circulating in Africa during 1996–1999: emergence of G9 strains and P[6] strains. Vaccine21(5–6), 361–367 (2003).
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Puustinen L et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants. Pediatr. Infect. Dis. J.23(10), 937–943 (2004).
   PubMed Web of Science ®Google Scholar
• Patel MM, Parashar UD. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs. J. Infect. Dis.200(Suppl. 1), S291–S299 (2009).
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Bilcke J, Ciarlet M et al. Rotavirus disease and vaccination: impact of genotype diversity. Future Microbiol.4(10), 1303–1316 (2009).
   PubMed Web of Science ®Google Scholar
• Kirkwood C, Boniface C, Barnes G, Bishop R. Rotavirus genotype distribution in Australian children – what has happened during the first 18 months after introduction of RotaTeq™ and Rotarix™. Presented at: Vaccines for Enteric Diseases Meeting. Malaga, Spain, 9–11 September 2009.
   Google Scholar
• Gurgel RQ, Correia JB, Cuevas LE. Effect of rotavirus vaccination on circulating virus strains [comment]. Lancet371(9609), 301–302 (2008).
   PubMed Web of Science ®Google Scholar
• Leite JP, Carvalho-Costa FA, Linhares AC. Group A rotavirus genotypes and the ongoing Brazilian experience: a review. Mem. Inst. Oswaldo Cruz.103(8), 745–753 (2008).
   PubMed Web of Science ®Google Scholar
• Nakagomi T, Cuevas LE, Gurgel RG et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch. Virol.153(3), 591–593 (2008).
   PubMed Web of Science ®Google Scholar
• Patel MM, de Oliveira LH, Bispo AM et al. Rotavirus P[4]G2 in a vaccinated population, Brazil [comment]. Emerg. Infect. Dis.14(5), 863–865 (2008).
   PubMed Web of Science ®Google Scholar
• Hull J, Teel E, Kerin T et al. Report of the U.S. rotavirus strain surveillance (1996–2008). Presented at: American Society for Microbiology Meeting. BC, Canada, 17–21 July 2009.
   Google Scholar
• Payne DC, Szilagyi PG, Staat MA et al. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr. Infect. Dis. J.28(11), 948–953 (2009).
   PubMed Web of Science ®Google Scholar
• Bhandari N, Sharma P, Taneja S et al. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. J. Infect. Dis.200(3), 421–429 (2009).
   PubMed Web of Science ®Google Scholar
• Bhandari N, Sharma P, Glass RI et al. Safety and immunogenicity of two live attenuated human rotavirus vaccine candidates, 116E and I321, in infants: results of a randomised controlled trial. Vaccine24(31–32), 5817–5823 (2006).
   PubMed Web of Science ®Google Scholar
• Barnes GL, Lund JS, Adams L et al. Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate. J. Paediatr. Child Health33(4), 300–304 (1997).
   PubMed Web of Science ®Google Scholar
• Barnes GL, Lund JS, Mitchell SV et al. Early Phase II trial of human rotavirus vaccine candidate RV3. Vaccine20(23–24), 2950–2956 (2002).
   PubMed Web of Science ®Google Scholar
• Ruiz LP Jr. Rotavirus vaccines. N. Engl. J. Med.354(16), 1747–1751; author reply 1747–1751 (2006).
   PubMedGoogle Scholar
• Kapikian AZ, Simonsen L, Vesikari T et al. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J. Infect. Dis.192(Suppl. 1), S22–S29 (2005).
   PubMed Web of Science ®Google Scholar
• Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J. Infect. Dis.168(2), 282–287 (1993).
   PubMed Web of Science ®Google Scholar
• Vethanayagam RR, Ananda Babu M, Nagalaxmi KS et al. Possible role of neonatal infection with the asymptomatic reassortant rotavirus (RV) strain I321 in the decrease in hospital admissions for RV diarrhea, Bangalore, India, 1988–1999. J. Infect. Dis.189(12), 2282–2289 (2004).
   PubMed Web of Science ®Google Scholar
• Mohan KV, Kulkarni S, Glass RI, Zhisheng B, Atreya CD. A human vaccine strain of lamb rotavirus (Chinese) NSP4 gene: complete nucleotide sequence and phylogenetic analyses. Virus Genes26(2), 185–192 (2003).
   PubMedGoogle Scholar
• Fu C, Wang M, Liang J, He T, Wang D, Xu J. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine25(52), 8756–8761 (2007).
   PubMed Web of Science ®Google Scholar
• Ciarlet M, Crawford SE, Barone C et al. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J. Virol.72(11), 9233–9246 (1998).
   PubMedGoogle Scholar
• Jiang B, Estes MK, Barone C et al. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles. Vaccine17(7–8), 1005–1013 (1999).
   PubMedGoogle Scholar
• Herrmann JE, Chen SC, Fynan EF et al. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis.174(Suppl. 1), S93–S97 (1996).
   PubMed Web of Science ®Google Scholar
• Coffin SE, Klinek M, Offit PA. Induction of virus-specific antibody production by lamina propria lymphocytes following intramuscular inoculation with rotavirus. J. Infect. Dis.172(3), 874–878 (1995).
   PubMedGoogle Scholar
• Conner ME, Crawford SE, Barone C, Estes MK. Rotavirus vaccine administered parenterally induces protective immunity. J. Virol.67(11), 6633–6641 (1993).
   PubMedGoogle Scholar
• Jiang B, Gentsch JR, Glass RI. Inactivated rotavirus vaccines: a priority for accelerated vaccine development. Vaccine26(52), 6754–6758 (2008).
   PubMed Web of Science ®Google Scholar
• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis.9(5), 565–572 (2003).
   PubMed Web of Science ®Google Scholar